JP2023544832A5 - - Google Patents
Info
- Publication number
- JP2023544832A5 JP2023544832A5 JP2023521503A JP2023521503A JP2023544832A5 JP 2023544832 A5 JP2023544832 A5 JP 2023544832A5 JP 2023521503 A JP2023521503 A JP 2023521503A JP 2023521503 A JP2023521503 A JP 2023521503A JP 2023544832 A5 JP2023544832 A5 JP 2023544832A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- insulin
- mammal
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063089122P | 2020-10-08 | 2020-10-08 | |
| US63/089,122 | 2020-10-08 | ||
| PCT/US2021/053537 WO2022076385A1 (en) | 2020-10-08 | 2021-10-05 | Methods and compositions for the treatment and prevention of type 1 diabetes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023544832A JP2023544832A (ja) | 2023-10-25 |
| JP2023544832A5 true JP2023544832A5 (https=) | 2024-08-21 |
Family
ID=81126224
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023521503A Pending JP2023544832A (ja) | 2020-10-08 | 2021-10-05 | １型糖尿病の治療および予防のための方法および組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240041986A1 (https=) |
| EP (1) | EP4225352A4 (https=) |
| JP (1) | JP2023544832A (https=) |
| CN (1) | CN116847869A (https=) |
| AU (1) | AU2021356578A1 (https=) |
| CA (1) | CA3193994A1 (https=) |
| WO (1) | WO2022076385A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3159054A1 (en) * | 2019-12-06 | 2021-06-10 | Mary S. MORRIS | Methods and compositions for the treatment and prevention of type 1 diabetes |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1409640A (zh) * | 1999-12-16 | 2003-04-09 | 伊莱利利公司 | 稳定性改善的多肽组合物 |
| US7279457B2 (en) * | 2004-03-12 | 2007-10-09 | Biodel, Inc. | Rapid acting drug delivery compositions |
| US20090023630A1 (en) * | 2005-01-31 | 2009-01-22 | Jan Wouter Drijfhout | Methods and Means for Use in Diagnostics and Treatment of Diabetes |
| AU2011202239C1 (en) * | 2010-05-19 | 2017-03-16 | Sanofi | Long-acting formulations of insulins |
| US9381247B2 (en) * | 2012-04-16 | 2016-07-05 | Biodel Inc. | Magnesium compositions for modulating the pharmacokinetics and pharmacodynamics of insulin and insulin analogs, and injection site pain |
| JP2020143105A (ja) * | 2014-01-09 | 2020-09-10 | サノフイＳａｎｏｆｉ | インスリンアスパルトの安定化された医薬製剤 |
| US10905727B2 (en) * | 2016-01-14 | 2021-02-02 | Intrexon Actobiotics N.V. | Compositions and methods for the treatment of type 1 diabetes |
| US20200087374A1 (en) * | 2017-02-06 | 2020-03-19 | Resiliun B.V. | Interaction between c-peptides and elastin receptor, a model for understanding vascular disease |
| EP3589271A4 (en) * | 2017-02-28 | 2021-01-06 | Biolingus IP LLC | OIL BASED FORMULATIONS FOR SUBLINGUAL AND BUCCAL ADMINISTRATION |
| CN110662551B (zh) * | 2017-06-01 | 2023-07-18 | 伊莱利利公司 | 速效胰岛素组合物 |
| EP3823644A4 (en) * | 2018-07-22 | 2022-06-08 | Minovia Therapeutics Ltd. | MITOCHONDRIAL AUGMENTATION THERAPY OF PANCREATIC DISEASES |
| CA3159054A1 (en) * | 2019-12-06 | 2021-06-10 | Mary S. MORRIS | Methods and compositions for the treatment and prevention of type 1 diabetes |
-
2021
- 2021-10-05 CN CN202180077223.6A patent/CN116847869A/zh active Pending
- 2021-10-05 WO PCT/US2021/053537 patent/WO2022076385A1/en not_active Ceased
- 2021-10-05 US US18/028,634 patent/US20240041986A1/en active Pending
- 2021-10-05 EP EP21878345.4A patent/EP4225352A4/en active Pending
- 2021-10-05 AU AU2021356578A patent/AU2021356578A1/en active Pending
- 2021-10-05 CA CA3193994A patent/CA3193994A1/en active Pending
- 2021-10-05 JP JP2023521503A patent/JP2023544832A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8192957B2 (en) | Fibrillation-resistant insulin and insulin analogues | |
| ES2799099T3 (es) | Proteínas de fusión | |
| ES2534434T3 (es) | Composiciones y métodos de uso de péptidos proislotes y análogos de los mismos | |
| US8299024B2 (en) | Methods to restore glycemic control | |
| US8937042B2 (en) | Pharmaceutical compositions comprising GLP-1 peptides or extendin-4 and a basal insulin peptide | |
| JP2021521230A5 (https=) | ||
| US20150086548A1 (en) | Methods and Compositions for Treating Type 1 and Type 2 Diabetes Mellitus and Related Conditions | |
| AU2015349743B2 (en) | ELP fusion proteins for controlled and sustained release | |
| US20150299286A1 (en) | Glutamic acid-stabilized insulin analogues | |
| US10822386B2 (en) | Insulin analogues with enhanced stability and reduced mitogenicity | |
| JP2003501068A5 (https=) | ||
| US12312390B2 (en) | Rapid-acting insulin analogues of enhanced stability | |
| KR20150021011A (ko) | 초고도 농축된, 속효성 인슐린 유사체 제형 | |
| JP2023544832A5 (https=) | ||
| GB2105191A (en) | Pharmaceutical formulations comprising human insulin and human proinsulin | |
| JP2023505190A5 (https=) | ||
| US20210371489A1 (en) | Site 2 single-chain insulin analogues | |
| US20150246129A1 (en) | Pharmaceutical composition | |
| US10995129B2 (en) | Non-standard insulin analogues | |
| HUT70176A (en) | Amylin antagonists and agonists |